{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:38:27Z","timestamp":1790779107115,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.ejps.2008.03.003","type":"journal-article","created":{"date-parts":[[2008,3,31]],"date-time":"2008-03-31T07:19:09Z","timestamp":1206947949000},"page":"149-163","source":"Crossref","is-referenced-by-count":28,"title":["Pharmacokinetic\/pharmacodynamic modelling of the EEG effects of opioids: The role of complex biophase distribution kinetics"],"prefix":"10.1016","volume":"34","author":[{"given":"Dorien","family":"Groenendaal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Freijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rosier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"de Mik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glynis","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Hersey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Ayrton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meindert","family":"Danhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.M.","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2008.03.003_bib1","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/jps.2600830915","article-title":"Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain","volume":"83","author":"Abraham","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2008.03.003_bib2","series-title":"NONMEM Users Guide","author":"Beal","year":"1999"},{"key":"10.1016\/j.ejps.2008.03.003_bib3","first-page":"1095","article-title":"Pharmacokinetic\u2013pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor","volume":"284","author":"Cox","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2008.03.003_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1056-8719(97)00065-8","article-title":"Pharmacokinetic\u2013pharmacodynamic modelling of the EEG effect of alfentanil in rats","volume":"38","author":"Cox","year":"1997","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejps.2008.03.003_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1023\/A:1020930626404","article-title":"A population pharmacokinetic\u2013pharmacodynamic analysis of repeated measures time-to-event pharmacodynamic responses: the antiemetic effect of ondansetron","volume":"27","author":"Cox","year":"1999","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejps.2008.03.003_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bcp.2003.08.027","article-title":"Variable modulation of opioid brain uptake by P-glycoprotein in mice","volume":"67","author":"Dagenais","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2008.03.003_bib7","first-page":"1121","article-title":"Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor","volume":"278","author":"Emmerson","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2008.03.003_bib8","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2008.03.003_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jchromb.2005.06.008","article-title":"High-performance liquid chromatography of nalbuphine, butorphanol and morphine in blood and brain microdialysate samples: application to pharmacokinetic\u2013pharmacodynamic studies in rats","volume":"822","author":"Groenendaal","year":"2005","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejps.2008.03.003_bib10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.bjp.0707257","article-title":"Population pharmacokinetic modelling of non-linear brain distribution of morphine: influence of active saturable influx and P-glycoprotein mediated efflux","volume":"515","author":"Groenendaal","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2008.03.003_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/sj.bjp.0707258","article-title":"Influence of biophase distribution and P-glycoprotein interaction on pharmacokinetic\u2013pharmacodynamic modelling of the effects of morphine on the EEG","volume":"515","author":"Groenendaal","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2008.03.003_bib12","first-page":"1084","article-title":"Active transport of fentanyl by the blood\u2013brain barrier","volume":"289","author":"Henthorn","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2008.03.003_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1023\/A:1011938112599","article-title":"Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat","volume":"15","author":"Letrent","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2008.03.003_bib14","first-page":"827","article-title":"Effects of a potent and specific P-glycoprotein inhibitor on the blood\u2013brain barrier distribution and antinociceptive effect of morphine in the rat","volume":"27","author":"Letrent","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2008.03.003_bib15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0006-2952(99)00180-X","article-title":"P-glycoprotein-mediated transport of morphine in brain capillary endothelial cells","volume":"58","author":"Letrent","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2008.03.003_bib16","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/jpet.104.079319","article-title":"Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood\u2013brain barrier permeability, plasma protein binding, and brain tissue binding","volume":"313","author":"Liu","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2008.03.003_bib17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.102.039255","article-title":"Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs","volume":"303","author":"Mahar Doan","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2008.03.003_bib18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF01061705","article-title":"Pharmacokinetic\u2013pharmacodynamic modeling of the central nervous system effects of heptabarbital using aperiodic EEG analysis","volume":"18","author":"Mandema","year":"1990","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejps.2008.03.003_bib19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1476-5381.1991.tb12230.x","article-title":"Pharmacokinetic\u2013pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration","volume":"102","author":"Mandema","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2008.03.003_bib20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/BF01080870","article-title":"Estimation of amobarbital plasma-effect site equilibration kinetics. Relevance of polyexponential conductance functions","volume":"19","author":"Mandema","year":"1991","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejps.2008.03.003_bib21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1021\/ci980339t","article-title":"Estimation of molecular linear free energy relation descriptors using a group contribution approach","volume":"39","author":"Platts","year":"1999","journal-title":"J. Chem. Inform. Comput. Sci."},{"key":"10.1016\/j.ejps.2008.03.003_bib22","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI118699","article-title":"P-glycoprotein in the blood\u2013brain barrier of mice influences the brain penetration and pharmacological activity of many drugs","volume":"97","author":"Schinkel","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2008.03.003_bib23","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1172\/JCI118214","article-title":"Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A","volume":"96","author":"Schinkel","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2008.03.003_bib24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/cpt1979253358","article-title":"Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine","volume":"25","author":"Sheiner","year":"1979","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.ejps.2008.03.003_bib25","doi-asserted-by":"crossref","DOI":"10.1208\/ps040438","article-title":"Pharmacokinetic\/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine","volume":"4","author":"Toutain","year":"2002","journal-title":"AAPS PharmSci."},{"key":"10.1016\/j.ejps.2008.03.003_bib26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1529\/biophysj.104.045633","article-title":"The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells","volume":"88","author":"Tran","year":"2005","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejps.2008.03.003_bib27","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/jps.20105","article-title":"Exact kinetic analysis of passive transport across a polarized confluent MDCK cell monolayer modeled as a single barrier","volume":"93","author":"Tran","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2008.03.003_bib28","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/00000542-200010000-00033","article-title":"The effect of altered cerebral blood flow on the cerebral kinetics of thiopental and propofol in sheep","volume":"93","author":"Upton","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejps.2008.03.003_bib29","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1124\/jpet.302.3.1158","article-title":"Mechanism-based pharmacokinetic\u2013pharmacodynamic modeling of concentration-dependent hysteresis and biphasic electroencephalogram effects of alphaxalone in rats","volume":"302","author":"Visser","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2008.03.003_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/cpt1974164691","article-title":"A safe method for rapidly achieving plasma concentration plateaus","volume":"16","author":"Wagner","year":"1974","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2008.03.003_bib31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00000542-200204000-00019","article-title":"Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein","volume":"96","author":"Wandel","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejps.2008.03.003_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1011555016423","article-title":"Evaluating pharmacokinetic\u2013pharmacodynamic models using the posterior predictive check","volume":"28","author":"Yano","year":"2001","journal-title":"J. Pharmacokinet. Pharmacodyn."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098708001954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098708001954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T12:00:54Z","timestamp":1546171254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098708001954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":32,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0928098708001954"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2008.03.003","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}